NCT05407441 2026-04-13Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def TumorsDana-Farber Cancer InstitutePhase 1/2 Active not recruiting49 enrolled
NCT07444619 2026-03-03A Phase I Study of Pazopanib in Combination With Trabectedin, Ipilimumab and Nivolumab (TraPIN) in Pediatric and Young Adult Patients With Recurrent Soft Tissue SarcomasM.D. Anderson Cancer CenterPhase 1 Not yet recruiting18 enrolled